Hottub News

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

3 reports from 3 outlets in 1 language · first reported · updated · JSON

Economy & businessScience & technologyTeva Pharmaceutical Industries LtdWorld Esperantist Vegetarian AssociationUnited States Food and Drug AdministrationXgeva

Reports

  1. Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)Published by manilatimes.net, GlobeNewswire — public companies ·
  2. Teva Pharmaceutical Industries Ltd: Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA (denosumab-adet), a Biosimilar to Xgeva (denosumab)finanznachrichten.de · en ·

More in Science & technology

  1. FTC probes AI labs over potential risks to consumers50 outlets
  2. 217-year-old mystery solved in six hours: AI deciphered Napoleon's letter43 outlets
  3. Meet the air traffic controller who flies himself to work47 outlets
  4. OpenAI notifies Australia about new attack by an agent76 outlets
  5. iPhone 18 Pro Max bug kills AT&T connection, leaving users needing a new phone32 outlets
  6. OpenAI Employee Quits Over 'Broken Culture', Calls For Aviation-Like Safety27 outlets